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Purpose: Our goal was to improve and standardize the procedure for subretinal injection of mouse eyes. Also, we wished
to optimize conditions for electroporation of retinal pigment epithelium (RPE) cells in the mouse eye with naked plasmids.
Methods: Mouse eyes were injected subretinally with reporter plasmid DNA, nanobeads, or buffer. A blunt needle was
introduced across the cornea, through the pupil, into the vitreous, until it made contact with the neural retina. Gentle
pressure was applied to the needle, forcing it to puncture the retina and enter the subretinal space. Fluid was injected
subretinally, raising large blebs evident on the mouse fundus. Subretinal injection surgery and outcomes were monitored
and evaluated by video recording. VidisicR aided in fundus examination of the blebs. Pores in RPE cells, across which
the plasmid in the fluid could diffuse, were created by several short electrical bursts. Expression of the delivered gene,
tdTomato,  in  the  plasmid  was  examined  under  fluorescence  microscopy  to  identify  targeted  cells.  Electroporation
conditions were varied from 0 to 200 V, 5 to 10 pulses, 0.1 ms to 100 ms duration of each pulse, and a space of 1.5 to 2
mm between electrodes on the cornea and sclera.
Results: A critical sign of surgical success was the appearance and persistence of three large blebs in the mouse eye. This
was illustrated by video recordings from two different systems. Application of VidisicR to the cornea made immediate
examination of the fundus possible at the end of the surgery. An 80% success rate was readily achieved by following this
method. Once a successful subretinal injection technique was established, electroporation conditions were evaluated.
Parameters of 50 V, 1 ms pulse duration, 5–10 pulses, 1 s apart and electrodes spaced 1.5–2 mm apart with the anode
placed on the sclera in the vicinity of the blebs produced a tight pattern of RPE transfection at approximately 30%
efficiency.
Conclusions: A standardized surgical method and a fast distinct indicator of successful surgery were essential to
establishing  a  gene  delivery  system  based  on  subsequent  electroporation.  With  the  surgery  better  controlled,
electroporation was adequate to transfect a substantial number of RPE cells in a defined position in the globe.
The  subretinal  space  is  an  excellent  target  for  drug
delivery  [1-5]  and  gene  therapy  purposes  [6-21].  This  is
because subretinal delivery places injected material in contact
with the plasma membrane of the photoreceptor (PhR) and the
retinal pigment epithelium (RPE) cells, and subretinal blebs
formed in that process regress quickly. Subretinal injection
surgery  is  commonly  used  clinically  and  has  been
demonstrated in many animal models. The small size of the
mouse eye and the relatively large size of the mouse lens make
the surgery more difficult in mice.
Timmers  and  coworkers  [22]  described  a  subretinal
injection approach into the eyes of rats via a transcorneal
route.  Other  researchers  have  used  a  transscleral,  route
entering at the limbus or pars plana, crossing through the
vitreous, penetrating through the diametrically opposite retina
into  the  subretinal  space  [23].  Some  routes  include  a
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transscleral-transchoroidal-Bruch's  membrane  approach
without  penetrating  the  retina  [24-26].  These  routes  are
effective  for  injecting  virus,  viral  particles,  liposomes,
plasmids,  drugs,  and  formulations,  or  in  collecting  the
contents  of  the  interphotoreceptor  (subretinal)  space.
However, the small size of the mouse eye and the comparative
toughness  of  the  sclera  increase  the  risk  of  accidentally
induced hemorrhages at the ciliary body or during penetration
of the choroid. These hemorrhages cause autofluorescence
and  retinal  damage,  rendering  further  treatment  or
experimentation futile.
External to the RPE cell are four barriers to the delivery
of DNA as a therapeutic agent [27,28]: matrices, dilution,
degradation, and impermeable membranes. The extracellular
matrix  of  the  subretinal  space  [29]  limits  convection  and
diffusion. Dilution reduces the yield of systemically delivered
drugs,  but  is  ameliorated  by  placement  of  the  drug
immediately  adjacent  to  the  target  cell.  Drugs  may  be
degraded or destroyed by enzymes [30]. The hydrophobic
character of the lipid bilayer prevents hydrophilic DNA from
crossing  the  membranes.  If  subretinal  injections  could  be
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problems by placing DNA immediately adjacent to the RPE
cell.
There are several ways to transfect DNA into target cells,
among  them  viral  or  viral-like  vectors,  spheroplasts  or
protoplasts  [31,32],  liposomes  [33,34],  physical
(electroporation  and  sonication)  [35-38],  chemical  (DNA
compaction  [39],  dendrimers  [40],  and  precipitates—e.g.,
calcium phosphate) [41]. Of these, viral vectors approach
100% transduction efficiency in cultured photoreceptor cells
[17],  and  electroporation  in  the  range  of  80%–90%
transfection efficiency [42]. Other chemical-based agents are
highly  successful  but  may  require  serum-free  conditions
[43], a state that is impossible in vivo. In this article, we
focused exclusively on electroporation as a simple mechanism
to deliver DNA to the RPE cell.
Internal to the cell, various barriers prevent the transport
of DNA into the nucleus. Entry to the nucleus can only be
gained by traversing several subcellular compartments, each
with  specific  barriers  to  diffusion,  movement,  and
permeability. The first major barrier is the sorting mechanism
by which cells separate internalized materials into degradative
pathways in lysosomes or the proteosome. Defenses against
viral or bacterial attack [44] act as barriers to therapeutic
vectors. The nuclear membrane and nuclear pore complex
block entry of large molecules that lack nuclear localization
signals. Once in the nucleus, episomal DNA can be inactivated
[45]. Finally, the cell can undergo apoptosis as a last resort
against delivery of drugs or DNA [46]. All these barriers must
be  overcome  for  efficient  gene  therapy.  Electroporation
circumvents  several  barriers  by  delivering  DNA  directly
across the plasma membrane into the cytosol. Delivery from
the cytosol into the nucleus is diffusion limited following
naked DNA delivery by electroporation.
Chalberg and coworkers [47,48] recently demonstrated
improved  transfection  efficiency  in  chick  chorioallantoic
membranes and living rabbit eyes by using shorter pulses of
higher  voltages  compared  to  previously  reported
electroporation conditions. We took a similar approach. As a
second-generation gene therapy strategy, electroporation is
inexpensive,  easy  to  replicate,  harmless  under  proper
conditions, robust across widely different eye diseases and eye
tissues, successful [36,37,42], already in use clinically for
drug  delivery  [49],  and  rapid  [50,51].  We  found
electroporation to work erratically in mice, because of the
delicacy of subretinal injection. In standardizing the method
of Timmers and coworkers [22], we found it to consistently
work well, once we added an evaluation of the fundus to the
procedure.
In this article, we present videos of the surgical technique
so that others can more readily learn and repeat our approach
and that of Timmers et al. [22]. Given this more reliable
surgery, it was possible to test the efficacy of subsequent
techniques and treatments performed after the surgery. We
were able to optimize electroporation to deliver plasmids to
RPE cells. We present these conditions and show high-level
reporter gene expression from plasmids in the RPE of the
living adult mouse. The expression levels might be sufficient
for gene therapy purposes.
METHODS
Mouse  husbandry:  Mice  were  used  according  to  ARVO
guidelines and as approved by the Emory Institutional Animal
Care and Use Committee. C57BL/6, 129/Sv, and Balb/C,
between 1 and 4 months old at time of surgery, were used.
Rpe65 knockout mice on a C57BL/6 background were used
in several control experiments. Mice were housed at 23 °C in
facilities  managed  by  the  Emory  University  Division  of
Animal Resources and given standard mouse chow (Lab Diet
5001; PMI Nutrition Inc., LLC, Brentwood, MO) and water
ad libitum. They were maintained on a 12 h:12 h light-dark
cycle, with daytime lighting ranging 200–750 lm outside the
cage depending on lower, middle, or top shelf position of the
cage rack. After experimentation, mice were euthanized by
CO2 asphyxiation.
Dissecting microscope systems: Subretinal injections were
performed using one of three different dissecting microscope
systems,  the  first  being  a  Seiler  Askania  SMC4  stereo
binocular microscope (Georgia Instruments, Inc., Roswell,
GA) with a halogen fiberoptic ring light (Fiberlite Model 180;
Dolan-Jenner, Inc., Boxborough, MA). This system did not
include  a  video  camera.  The  second  system  was  a  Wild-
Heerbrugg  M691  stereo  binocular  microscope  (Leica
Microsystems, Bannockburn, IL) fitted with a Hitachi KP-
D20BU color CCD video camera (Hitachi, Tokyo, Japan) and
a  Panasonic  DMR-E95H  DVD  recorder  (Panasonic
Electronic Devices, Knoxville, TN). The third system was an
Olympus  SZX2-ZB16  stereo  microscope  (Hunt  Optics;
Pittsburgh, PA), which was equipped with a ring light source
(Schott; Auburn, NY), and a Panasonic GPUS932HT HD
Video camera (Hunt Optics and Imaging) to record subretinal
injections. The camera was interfaced to an KONA LHe HD-
video capture card (AJA Video Systems, Grass Valley, CA)
installed in a Mac Pro (Apple Computer, Cupertino, CA)
running OSX Leopard 10.5.3, and the videos were edited with
Final Cut Pro (version 6; Apple Computer).
Surgical  equipment  and  instruments:  A  NanoFil™  Sub-
microliter injection system with a UMP-II microsyringe pump
and Micro4 controller with a footswitch was procured from
World Precision Instruments (WPI, Sarasota, FL). A heating
pad and pump were used to maintain the mice at 37 °C during
anesthesia  (T/Pump  TP500;  Gaymar,  Orchard  Park,  NY).
Also  obtained  from  WPI  were  beveled  34  gauge  needles
(catalog  number  NF34BV-2)  and  curved  forceps  (catalog
number 15915). Most other incidental equipment and tools
were from Fisher Scientific (Pittsburgh, PA) or VWR (West
Chester, PA). Dr. Mann Pharma, Berlin, Germany, distributes
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clear ocular hydro-gel, which contains high molecular weight
polyacrylic acid. It was the kind gift of Dr. Philipp Lirk,
Department of Anesthesiology and Critical Care Medicine,
Medical University Innsbruck, Austria.
Surgical technique: Sterile surgical technique was employed
for all surgeries, which were performed between 8:00 AM and
6:00 PM (one hour after lights on to one hour before lights
off).  Fluid  lines,  surgical  instruments,  and  needles  were
sterilized by repeated rinsing with 70% ethanol and sterile
water. The 34-gauge beveled needle could be used 15 to 20
times before replacement.
Mice were anesthetized with 80 mg ketamine and 12 mg
xylazine per kilogram bodyweight (K-113; Sigma-Aldrich,
St.  Louis,  MO)  and  achieved  adequate  anesthesia  in
approximately 5 min. Each mouse was kept on a 37 °C pad
after it was anesthetized, during and after surgery. The cornea
was  topically  anesthetized  with  one  drop  of  proparicaine
(proparacaine hydrochloride ophthalmic solution USP, 0.5%;
National  Drug  Code,  [NDC]  17478–263–12;  Akorn  Inc.,
Buffalo Grove, IL). The pupil was dilated with one drop of
tropicamide  (tropicamide  ophthalmic  solution  1%;  NDC
61314–355–01; Falcon Pharmaceuticals, Ft. Worth, TX) and
was usually fully dilated within 90 s. If necessary, another
drop of tropicamide was placed on the cornea should the pupil
not adequately dilate in that time. After dilation, it usually took
about 90 s to complete the surgery.
The mouse was positioned with its nose pointing away
from the surgeon and its left eye facing up toward the ring
light and the microscope. A drop of the carbomer eye gel
VidisicR  was  placed  on  the  mouse  cornea.  A  22×40
microscope coverslip was grasped by hand and adjusted on
the VidisicR eye gel in such a way that the fundus, its blood
vessels, and the optic nerve head could be easily seen. This
served as a means to assess the condition of the eye before
injection and as a comparison for the postoperative condition
of the retina. The coverslip was removed before the surgery
was started.
Mice  were  not  immobilized  during  the  surgical
procedure. Instead, after each mouse was placed on a heating
pad, its left eye was grasped with curved forceps held in the
surgeon's left hand so that the eye was slightly proptosed from
pinching of the forceps. A 34 gauge beveled needle, held in
the surgeon’s right hand, was used as a lance to make a full-
thickness cut through the cornea near the limbus, penetrating
upward  into  the  anterior  chamber  at  an  oblique  (nearly
tangential) angle. It was found that some tissue stretching
allowed  the  wound  to  effectively  reseal  itself  following
removal of the needles. The beveled needle was removed and
replaced with a blunt 35 gauge needle that was attached to an
injection  system  (WPI).  The  tip  of  the  blunt  needle  was
advanced into the anterior chamber until it was centered on
the optical axis. With a sweeping motion, the needle tip of the
needle was moved through the pupil, around the lens, and into
the vitreous. While a rare occurrence, if the lens were nicked,
the  surgery  was  abandoned.  There  was  no  evidence  of
displacement of the lens following surgery, even though it
would seem that some of the zonules of Zinn ought to be
damaged.
The needle tip was advanced to the retina opposite to the
puncture site until it was but a few tip diameters away from
the optic nerve head. The lens magnified the view of the
needle. A gentle amount of pressure (the touch of which must
be learned by experience) was applied to penetrate the neural
retina into the subretinal space, but not so much that the tip
penetrated or damaged the RPE sheet. Blood flow into the
vitreous meant the tip pressure was too great. A bolus in the
vitreous  indicated  the  pressure  was  not  enough  and  the
injection had not filled the subretinal space. The nanojector
system was set to deliver 1000 nl at a rate of 170 nl/sec, which
allowed for acceptable filling of the subretinal space. It can
be useful for an assistant to press the injection button on the
face of the nanojector, or alternatively a foot-pedal can be used
to activate the microinjector pump. Faster or slower injection
rates have not been systematically investigated, but this rate
provided  acceptable  filling  of  the  subretinal  space  in  our
hands. The needle was left in position for another 5–10 s to
allow pressure in the injection system to equilibrate with the
eye pressure and then removed by pulling backwards at a slow
pace to allow the hole in the retina to reseal and to avoid
damaging  the  lens,  iris,  and  corneal  endothelium  during
removal. After surgery more of the VidisicR gel was placed on
the eye, and fundus was examined for the presence of blebs.
Triple  antibiotic  ointment  (Taro  Pharmaceuticals,  Inc.,
Hawthorne,  NY),  which  contains  bacitracin,  neomycin
sulfate, and polymyxin B, was placed on the eye as per ARVO/
IACUC guidelines. The mouse was kept on a 37 °C heating
pad until it was awake, then it was transferred to recover in a
cage by itself for 1 to 2 h. Afterwards, it was moved to its
home cage and cage mates until analysis, usually 3 to 4 days
after treatment.
Worksheet: A record of the procedure was kept. Documented
were ear number (ear tags from WPI) of the mouse, date of
birth, sex, amount of anesthesia, bleb size (small, medium, or
large),  and  number  of  blebs.  Also  recorded  were  any
complications including hemorrhage, lens damage, corneal
clouding, or the presence of air bubbles.
Reporter gene plasmid: The base vector was the mammalian
expression vector pVAX™200-DEST (Invitrogen, Carlsbad,
CA). tdTomato cDNA was PCR amplified from pRSETB-
tdTomato with primers bearing AttB sites and incubated with
BP  ClonaseII  and  the  pVAX™200-DEST  plasmid.  The
resulting  reporter  expression  plasmid,  called  pVAX-
tdTomato  [52],  contained  the  CMV  Immediate  Early
promoter driving expression of tdTomato. Located on the 3′
flanking side of the tdTomato cDNA was a bovine growth
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Kanamycin resistance gene for selection and growth. A map
of the plasmid is shown in Figure 1. This plasmid was a kind
gift from Dr. Ton N.M. Schumacher of the Department of
Immunology, The Netherlands Cancer Institute, Amsterdam,
The  Netherlands.  Plasmid  was  isolated  from  transformed
DH10B Escherichia coli grown overnight in Luria broth using
a Qiagen maxi-prep kit following the manufacturer's protocol.
An endotoxin-free kit was not needed for these experiments.
Sample  preparation:  Plasmid  DNA  was  resuspended  in
nuclease-free sterile water at 2 mg/ml. The plasmid solution
was  centrifuged  at  10,000x  g  for  5  min  to  sediment  any
particulates from the solution that might clog the 35 gauge
needle. This was done immediately before loading the needle
and injection syringe.
Quantum  dots  with  a  600  nm  fluorescence  emission
maximum  (EviTags,  E2-C11-NF2–0600;  Evident
Technologies,  Troy,  NY)  were  injected  as  the  stock
preparation. These dots have a tendency to aggregate, and the
aggregates can clog a 35 gauge needle and tubing in the
injector system.
Electroporation: Immediately following subretinal injection,
any plasmid-treated mouse eyes or control (vehicle only) eyes
were subjected to electroporation. The electroporation source
was  a  commercial  square  wave  generator  (BTX  model
ECM830;  Harvard  Apparatus,  Holliston,  MA).  Electrodes
Figure 1. A map of the expression plasmid, pVAX-tdTomato. This
expression plasmid was created [52] by inserting tdTomato cDNA
into  the  pVAX™200-DEST  plasmid  (Invitrogen).  The  CMV
Immediate Early promoter drives expression of tdTomato. Located
on the 3′ flanking side of the tdTomato cDNA is the bovine growth
hormone  poly(A)  signal.  The  plasmid  bears  the  Kanamycin
resistance gene, the pUC origin of replication, and attB sites.
were  made  by  wrapping  platinum-iridium  20  gauge  wire
(catalog number 50822164; Fisher) around a sharpened pencil
tip, creating a 1.5 to 2 mm loop. The loops were clipped to
small  test-jumper  leads  (catalog  number  278–001;  Radio
Shack Corporation, Fort Worth, TX) and thence to the BTX
electroporator. One platinum loop was positioned directly
underneath the retina injection site on the scleral surface of
the  mouse  globe,  and  the  other  loop  was  positioned
diametrically opposite from the injection site. The electrodes
were spaced roughly 1.5 to 2 mm apart. The loop underneath
the injection site served as the positive (anodal) electrode to
drive the negatively charged plasmid DNA toward RPE cells.
Optimal  conditions  and  minimum  requirements  were
investigated by varying the voltage, pulse length, number of
pulses, and number of pulse trains. An optimum was found
with 50 V, 10 pulses, 1 ms pulse duration, 1 s interval between
pulses, and one pulse train. The range of conditions tested
were: 0.1 ms to 100 ms (0.1, 0.25, 0.5, 1, 10, 25, 50, and
100 ms) for pulse length, 0 to 200 V for potential difference
(0, 5, 8, 10, 20, 25, 30, 40, 50, 70, 80, 100, 150, 200 V), 5, 10,
and 20 pulses, 0.125 and 1 s interval between pulses, and one
or two pulse trains. Typical controls included either omitting
plasmid  (vehicle-only  subretinal  injection)  or  omitting
electroporation in different mice. The contralateral eye served
as the uninjected control in most mice.
Analysis of in vivo RPE transfection: A tight pattern of heavy
reporter  gene  expression  (as  evidenced  by  fluorescence
focused in RPE cells directly over the anode in the RPE sheet)
was considered to be an optimal result. Treated and control
eyes were harvested from 1 to 14 days after injection. Reporter
gene expression was examined by cutting frozen sections of
the globes through the center of the eye, the optic nerve head,
and the center of the cornea in a superior-inferior plane [53,
54] or by creating flatmounts of the entire eyecup [55]. The
eyes were fixed in 10% buffered formalin (10% buffered
formalin  phosphate;  catalog  number  SF100–4;  Fisher
Scientific) for 30 min on ice, and then rinsed three times in
cold PBS for 5 min each.
Frozen  sections:  Eyes  were  harvested  following  CO2
asphyxiation of the mouse. The intact eye was fixed for 30
min in ice-cold 10% buffered formalin (Fisher Scientific),
rinsed  for  5  min  three  times  in  ice-cold  Dulbecco’s  PBS
(dPBS; product number 14200; Invitrogen), and transferred
to 20% sucrose in dPBS. After about 15 min, the eye began
to sink, and it was dipped three times in a 1:1 mixture of 20%
sucrose:tissue freezing medium (Jung; Leica Microsystems,
order number 0201 08926, distributed by Vashaw Scientific,
Inc., Norcross, GA). The eye was oriented in a cryomold
containing 0.5 ml tissue freezing medium and frozen slowly
on a plastic canoe floating on liquid nitrogen, and stored at
−80 °C until sectioning. Samples were cut at 8 μm; every fifth
section was taken on a Leica CM1850 cryostat set to −22 °C
(Leica Microsystems). Sections of the globes were cut through
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the  cornea  in  a  superior-inferior  plane  [53,54,56]  and
collected  onto  Fisher  superfrost  microscope  slides.  Slides
were stored at −80 °C until staining.
Nuclear staining: For DAPI staining of nuclei, slides were
removed from the −80 °C freezer and dried under a fan for 30
min. Slides were dipped in dPBS, and about 25 μl Vectashield
mounting  medium  with  DAPI  (catalog  number  H-1200;
Vector Laboratories, Inc., Burlingame, CA) were added, and
a coverslip placed on top. For Yo-Pro-1 (Invitrogen) staining
of nuclei, sections were air-dried and incubated with 4 μM
Yo-Pro-1 stain (diluted with dPBS from a stock solution of
1 mM in DMSO) for 1 h, then mounted in Vectashield Hardset
(H-1400; Vector Laboratories). Slides were then examined
under confocal microscopy.
Antibody staining of RPE65: The mouse antibody PETLET
[57] was used at a 1:500 dilution in 1% BSA and dPBS.
Sections were treated at 4 °C overnight. The primary antibody
was washed off three times in dPBS, and a rabbit anti-mouse
secondary antibody labeled with AlexaFluor-488 was applied
at a dilution of 1:2000 and incubated at room temperature for
2 h. The excess secondary antibody was rinsed off with three
changes of dPBS, and the section was mounted in Vectashield
Hardset (Vector Laboratories). Rpe65 knockout mouse eye
sections were used as negative controls with this antiserum.
Confocal microscopy: Confocal microscopy was performed
using a Nikon Ti inverted microscope equipped with a C1-
plus confocal scan head and filter-based detector and 402 nm
diode, argon gas, 561 nm diode and 638 DPSS lasers (Nikon
Instruments, Melville, NY). The software used to capture the
images  was  Nikon  EZ-C1  Gold  version  3.60.  DAPI  was
excited using a 402 nm laser line, and emissions were filtered
using a 450/35 and 675/50 dual bandpass filter. TdTomato
was  excited  using  561  nm  laser  line  and  emissions  were
filtered  using  a  605/75  bandpass  filter.  AlexaFluor-488
(Invitrogen) and Yo-Pro-1 (Invitrogen) fluors were excited
using the argon gas 488 nm laser line and emissions were
filtered through a 515/30 bandpass filter.
Apoptosis  detection:  Cells  were  stained  for  detection  and
quantification  of  apoptotic  cells.  A  DeadEnd  TUNEL  kit
(product number G3250; Promega, Madison, WI) was used
according to the manufacturer’s instructions.
Flatmounting: The eyecup flatmount included all the cornea
and sclera, the neural retina and uveal tract, but the lens was
Figure 2. The subretinal injection technique. A: Position of the 34 gauge beveled needle is shown nearly tangential just before lancing the
cornea. B: This schematic illustrates the position of the 35 gauge blunt needle after puncturing the neural retina and partially inflating the
interphotoreceptor space (the subretinal space) to produce subretinal blebs. C: Presented is a still image from a video illustrating penetration
of the cornea. D: This panel shows the positioning of the 35 gauge blunt needle in the center of the anterior chamber. E: The 35 gauge needle
penetrates through the retina into the subretinal space. F: The 35 gauge needle is removed from the vitreous after subretinal injection of
quantum dots. A small number of quantum dots are evident in the vitreous that generate a reddish-orange color. G: Illustrated is a fundus
before subretinal injection. The retinal vessels can be readily detected in the fundus image. A ruddy red background color can be observed
before injection. H: Shown is the fundus immediately after subretinal injection. The positions of three blebs surrounding the optic nerve head
are located at clock face positions 4, 8, and 11. Each bleb appears puffy and gray in color with red vessels between the blebs. The optic nerve
head is nearly centered in the image of the fundus. The imaged mouse eyes are about 3 mm in diameter.
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27 gauge needle, and iridectomy scissors were used to make
four to six radial cuts, starting at the center of the cornea, and
extending toward the optic nerve. If necessary, a fresh razor
blade or disposable cryotome blade was used to extend the
initial cuts started with the iridectomy scissors. The flattened
eyecups were placed on microscope slides in 100 μl of dPBS.
This solution kept the tissue moist before and in between
staining steps. These staining solutions were pipetted on and
off with handheld pipettors, but otherwise did not differ from
staining procedures for frozen sections.
Fluorescence  detection  of  reporter  gene  expression:
Detection  of  reporter  gene  expression  was  conducted  by
fluorescence microscopy. The tdTomato reporter gene has an
excitation optimum at 395 nm and a lesser peak at about 460–
490, an emission maximum at 581 nm. Compared to other
naturally  fluorescent  proteins,  tdTomato  has  reduced
photobleaching  and  provides  excellent  fluorescence  [59].
Epifluorescence  microscopy  was  used  to  detect  this  red
fluorescence. For the photomerged flat mounts, we used an
inverted microscope (Diaphot 300; Nikon Instruments) with
a  triple-bandpass  filter  cube  (DA/FI/TX-B;  Semrock  Inc.,
Rochester, NY) and a ProgRes CF CCD camera (Jenoptik
Laser  Optik  Systeme  GMBH,  Jena,  Germany).  When  we
found an area of interest, we used the aforedescribed confocal
system to obtain a detailed image of the RPE cells expressing
the tdTomato.
Figure 3. Subretinal injection by transcorneal route. This video was
created on a Wild-Heerbrugg dissecting microscope equipped with
a ring light and a standard definition CCD video camera. Double-
click on the image to play the video. Note that the slide bar at the
bottom of the quicktime movie can be used to manually control the
flow of the movie. A representative frame from the movie is included.
This image illustrates the transcorneal puncture.
RESULTS
Basic subretinal injection procedure and videos: Figure 2
provides static images of the subretinal injection technique.
Two videos of the surgical procedure are illustrated in Figure
3 and Figure 4. These videos were made with two separate
dissecting microscopes and two different video cameras that
allow a comparison of contrast, illumination, and depth of
field. These videos and images (Figure 2, Figure 3, and Figure
4) illustrate the successful surgery and injection procedure,
highlighting the correct techniques.
Potential  pitfalls:  The  costs  (in  time,  effort,  and  mental
energy)  associated  with  optimizing  this  procedure  can  be
significant.  Table  1  presents  some  of  the  problems  we
Figure 4. Subretinal injection by transcorneal route. This video was
created on an Olympus dissecting microscope equipped with a ring
light and an HD video camera. Double-click on the image to play the
video. Note that the slide bar at the bottom of the quicktime movie
can  be  used  to  manually  control  the  flow  of  the  movie.  A
representative  frame  from  the  movie  is  included.  This  image
illustrates the transcorneal lance.
TABLE 1. TROUBLESHOOTING GUIDE FOR SUBRETINAL INJECTION.
Problem Probable cause Solutions
Lens cloudy Lens capsule nicked during
surgery
Avoid the lens.
No blebs Not penetrating the retina Press a little harder.
No blebs Torn retina or retina hole;
fluid leaks out quickly into
vitreous
Penetrate retina in a single
motion.
No blebs or a poorly inflated
bleb
Fluid leaks out quickly into
vitreous
Pause for 5–10 s before
removing the blunt needle
from the subretinal bleb. This
allows pressure equilibration.
Blood Penetrating into the choroid Press gently.
Blood Nicking the ciliary body Sweep closer to lens.
Cloudy cornea Eye was not kept moist
before surgery
Apply lubricating eye drops
between proparicaine and
tropicamide application.
Air bubbles Air lines or solutions not
degassed
Degas solutions. Flush the
lines and prime them with
water before filling with
delivery solution.
This table summarizes a few of the common problems that
have  been encountered while attempting subretinal injection
of the adult mouse eye.
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2216encountered with the injection technique and solutions we
found.
Signs of a successful procedure: Careful examination of the
adult mouse fundus, after surgery, was an easy way to evaluate
the success or failure of the injection. In most cases, the fundus
could be observed directly through the dissecting microscope
after removal of the injection needle, but on occasion a little
more VidisicR needed to be applied to the injected eye, or a
coverslip had to be placed in contact with the gel.
Three blebs underlying the neural retina was a sign of
proper inflation of the subretinal space in the adult mouse eye.
These blebs were clearly visible, and they demonstrated that
the injected material was well confined within the subretinal
space. We did not observe any cases of more than three blebs
being formed. Eyes with only one or two blebs were usually
accompanied by evidence of a torn or damaged retina, as seen
on funduscopic examination. Mice without three blebs were
excluded from experimental test groups, and the injection was
considered unsuccessful. There are several causes of incorrect
inflation of the subretinal space: 1) material was injected into
the vitreous; 2) fluid rapidly leaked out of the subretinal space
into the vitreous through a retina hole; 3) retina was hopelessly
torn; 4) material was injected elsewhere; 5) pump did not
operate correctly; 6) needle was clogged; or 7) material was
injected  suprachoroidally  or  subchoroidally.  Evidence  of
blood in the vitreous or aqueous, or nicking of the lens were
other  indicators  of  problems,  and  mice  with  these  were
rejected as well. All signs could be readily observed during
fundus examination.
Quantum  dots:  The  boundaries  of  the  injection  site  were
mapped with nondegradable nanoparticles that were injected
into  the  subretinal  space.  The  blebs  raised  by  injection
regressed within 24 h, and the eyes harvested. Frozen sections
were  taken  to  examine  whether  the  quantum  dots  were
confined to the subretinal space (Figure 5). A great amount of
red fluorescence was present in the subretinal space. Only
small numbers of quantum dots were seen in locations other
than the subretinal space, suggesting little leakage from the
site of injection. These included small numbers in the optic
nerve and a few dots near the initial puncture in the cornea. A
small  number  of  dots  were  found  in  the  vitreous.  In  the
location of the resorbed bleb, the outer nuclear layer, inner
nuclear  layer,  and  ganglion  cell  layer  all  exhibited
qualitatively normal thicknesses. Figure 5D shows a close-up
of the retina, subretinal space, and the RPE. The quantum dots
(red  fluorescence)  seen  in  this  image  were  apparently
internalized (perhaps by phagocytosis and endocytosis) into
the RPE cells. The nuclei had been stained with Yo-Pro-1,
which stains nuclei green (Figure 5D). These experiments
with quantum dots established the boundaries of the subretinal
injection site, a comparative absence of leakage out of the
bleb, and provided a long-term marker of the deposition site.
Optimized  expression  of  tdTomato:  Once  standardized
conditions for the subretinal injection were established, it was
possible  to  systematically  examine  the  efficacy  of  gene
delivery by electroporation into the RPE cells in the adult
mouse eye. In Figure 6, we illustrate the technique and optimal
electroporation conditions. Figure 6C shows a tightly focused
cluster of RPE cells that express tdTomato. Close-ups (Figure
6D) of this tight patch revealed about 30% of the cells were
red. The polygonal pattern of RPE cells was observed in both
transfected  and  nontransfected  cells,  and  there  was  no
characteristic bias in the transfection of cells of lesser or
greater polygonality. Figure 6E,F show the red fluorescence
illuminating  polygonal  or  cobblestone-like  cell  borders,
characteristic of RPE cells. Cross-sections (Figure 7) revealed
the red cells to be in the RPE cell layer and to be the size of
RPE cells, subtending about 50 nuclei in the outer nuclear
layer.
Tissue  death  under  these  optimized  conditions  was
examined (Figure 8). A limited number of apoptotic cells were
detected as reflected by punctate green fluorescence in the
outer nuclear layer in cross-sections. No green nuclei were
detected in the RPE cell layer.
Several  parameters  of  electroporation  were  varied  to
deliver pVAX-tdTomato and to measure its expression level
(Figure  9  and  Figure  10).  Conditions  resembling  those
previously  used  in  other  electroporation  studies  for  other
species, and for other ages of mice, were employed (Figure
9). All these conditions revealed expression of tdTomato in
the RPE with some expression in the cornea, ciliary body, and
iris. In some cases, the expression was widely distributed
across the flatmount.
Figure  10  shows  the  optimization  and  minimum
requirements of voltage for fixed numbers of pulses and a
uniform pulse duration. Up to 25 V was not sufficient to
generate any tdTomato expression. A range of 40 to 70 V was
sufficient.  At  100  V  some  tissue  damage  occurred  and
expression extended into the cornea, ciliary body, and iris.
Pulses of 1 ms produced a tightly confined area immediately
overlying the bleb and the anode (Figure 10). There seemed
to be a higher density of RPE cells that were transfected within
this confined area, suggesting that shorter duration pulses
helped to create a high level of transfection and lower cell
death close to the anode. A third variable was the number of
pulses, either 5 or 10. There was little difference between the
two  at  longer  pulse  durations.  It  appeared  that  10  pulses
marked a trend toward more transfected cells under the 1 ms,
50 V condition (Figure 10). More work is needed to discern
whether the number of pulses can be further optimized, and
as a note of caution, each brand of electroporator may have its
own optimal conditions.
Figure 11 shows the expression of tdTomato (red) and the
localization of Rpe65 protein (green) within RPE cells of
wild-type mice. Rpe65 and tdTomato both localized to the
RPE  cell.  Rpe65  protein  and  tdTomato  accumulated  in
slightly  different  positions  within  the  RPE  cell,  with  the
Molecular Vision 2008; 14:2211-2226 <http://www.molvis.org/molvis/v14/a259> © 2008 Molecular Vision
2217Figure 5. Quantum dots in the whole eye after subretinal injection. The mouse was sacrificed 24 h after injection of the quantum dots. This
length of time allowed the three blebs to resorb and the neural retina to return to contact with the RPE sheet. Cryosections were collected and
counterstained with DAPI (to stain all nuclei blue). A: Shown is a composite of numerous images originally collected with a 20X objective.
Images were fused in Photoshop with the Photomerge tool (Adobe Systems Inc., San Jose, CA). The cornea was lanced at clock face position
11, and a small number of quantum dots can be seen in the corneal stroma at the wound site. The retina was punctured between clock face
positions 4 and 5. The bright yellow represents intense fluorescence of highly concentrated quantum dots located in the subretinal space. There
is a continuous gradient of color from bright yellow to purple, indicating successively less fluorescence of the quantum dots in proportion to
their concentration. The quantum dots were confined specifically to the subretinal bleb. The scale bar represents 500 μm. B: A few dots were
found in the optic nerve head and interstitial spaces in the optic nerve, as indicated by the red and purple colors. C: A distinctive gradient of
color from bright yellow to purple is illustrated from right to left within the confines of the subretinal space. The comparative absence of any
color other than blue-stained nuclei in the section suggests that there was no break in the RPE sheet or tear in the neural retina during subretinal
injection. D: Close-up reveals quantum dots phagocytosed within the RPE cells. Quantum dots (red) were detected at the level of the RPE
cells, and the dots surround the Yo-Pro-1 stained nuclei (green) of the RPE cells. This location indicated that the quantum dots were internalized
into the RPE cells. The scale bar represents 50 μm.
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2218Rpe65 protein in the more apical half of the cell, and the
tdTomato protein found in the more basal and perinuclear
regions.
DISCUSSION
Improvements to subretinal injection: This technical brief
considers  some  of  the  difficulties  associated  with  the
combination of subretinal injection and electroporation of a
naked  plasmid.  The  great  variability  in  outcomes  of  the
subretinal injection in the mouse eye accounted for most of
the overall experimental variability in delivery of genes to the
PhR and RPE cells when subretinal injection was followed by
electroporation. Here we standardized our injection technique
and  demonstrated  our  current  surgical  technique  in  video
form, so that the reader can duplicate and possibly improve
upon our present technique. This technique was successful in
our  hands  about  80%  of  the  time,  but  it  still  required  a
significant amount of time to learn. Depending on the amount
of practice and prior surgical skills, we found it took 50–100
surgeries to become proficient in the injection of the adult
mouse  eye.  This  is  in  contrast  to  other  researchers’
descriptions of the relative ease [22] and our experience in the
subretinal injection of neonatal rat pups, which we found
Figure 6. Expression of a reporter gene in RPE cells; subretinal injection and electroporation under optimized conditions. Red fluorescence
of tdTomato expression was observed following subretinal injection and electroporation under optimized conditions; individual RPE cells
were resolved. The cells include neighbors with and without tdTomato fluorescence (red). About 30% of the cells in electroporated area were
positive for tdTomato gene expression. This field represents the RPE cells located directly over the anode. TdTomato-expressing cells exhibited
polygonal shapes characteristic of normal RPE cells. The electroporation conditions employed were 50 V, 2 mm gap between electrodes, 1
ms pulse duration, and 10 pulses at 1 s intervals. A: In this schematic of the eye, the bleb is in green and the positive electrode in red. The
black electrode represents the negative electrode. B: Presented is a wholemount of the eye after bleb formation but without voltage applied
to the electrodes. The edges of the flatmounts are outlined in white and form a floret shape. The center of the floret corresponds to the retina
while the outer half of the “petals” correspond to the cornea. C: Shown is a wholemount of the eye following subretinal injection and
electroporation under the optimized condition. A focused patch of red fluorescent cells is evident near the center of the floret. Each dot
represents a separate RPE cell. This region of the retina corresponds to the bleb and the location of the anode. D: High magnification of the
fluorescent region shows about 30% of the RPE cells manifesting tdTomato fluorescence. E: Close-up of a cluster of tdTomato fluorescence
in cells reveals a cobblestone or polygonal shape. F: Shown is a close-up of a single binucleate RPE cell. In B and C, images are about 9 mm
across. The scale bar in D represents 50 μ. The scale bars in E and F represent 25 μm.
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2219quick  and  easy  to  learn.  In  addition,  we  found  that  the
microscope itself was not a major variable in the ability to
conduct the subretinal injection or observe the fundus. Three
microscopes of widely different cost and quality were all used
successfully,  provided  that  there  was  adequate  working
distance from the mouse to the objective of the microscope.
We found the outcome of the surgery could be rapidly
determined postoperatively by examining the adult mouse
fundus. The subretinal injection raised blebs, indicating that
the retina was elevated from the RPE sheet, and the persistence
of these blebs demonstrated the retinal hole had sealed. No
bleb meant that the surgery had failed, and the mouse should
not be used for further experimentation. We expected only one
large  bleb,  because  that  is  what  has  traditionally  been
observed  in  subretinal  injections  of  neonatal  rat  pups.
However, we found the best outcomes were when there were
three blebs, and when the perimeters of these blebs, as viewed
by fundoscopy, were demarcated by major blood vessels.
Rarely did we observe a single large bleb or two blebs. It is
possible that the mouse retina is attached or anchored to the
underlying RPE at spots or streaks due to penetrating blood
vessels or nerves, and these anchor points may cause multiple
blebs instead of one huge one. The blood vessels may be
tougher under tension than the more balloon-like, pliant, and
weaker neural retina, which can distort its shape more and
stretch  to  inflate  the  subretinal  space  between  the  major
arcades of the blood vessels. Several blebs can then be raised,
each between the boundaries established by the presence of
Figure 7. Electroporation of the mouse eye viewed in cross section. A, B, and C: Demonstrated are the results of representative experiments
with optimized electroporation conditions after the subretinal injection of pVAX-tdTomato [52]. The cross-sections were cut with a cryostat
and nuclei stained with DAPI. A, B, and C all illustrate specific expression of tdTomato in the RPE cell layer. The red RPE cells each appear
to subtend a region of about 50 nuclei in the outer nuclear layer, consistent with the known relationship of each RPE cell supporting numerous
PhR cells. The scale bar represents 50 μm.
Figure 8. Expression and death assessment in the retina following subretinal injection and electroporation of pVAX-tdTomato. A: Cross-
sections of the retina were cut with a cryostat. Red fluorescence was detected in a single cell found in the RPE layer. This image is the red
channel from a confocal image. B: TUNEL staining (green channel) was done in the same section. This panel shows three TUNEL-positive
nuclei in a field of roughly 400 nuclei in the PhR cell layer in the image. C: A and B were merged and show the DAPI channel (blue) of the
same section. The scale bar represents 50 μm.
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2220Figure 9. Subretinal injection followed by electroporation, and analysis of flatmounts. Four different electroporation programs were employed
to compare qualitatively their efficacy. These conditions resembled the voltage, pulse duration, and train of four different published techniques
to electroporate the retina and RPE sheet in other species and at differing stages of development. A: The conditions were 30 V, 8 pulses, 50
ms duration per pulse, and an interval of 0.1 s between pulses [61]. B: The conditions were 38 V, 5 pulses, 50 ms duration, and 1 s between
pulses [62]. C: The conditions were 50 V, 5 pulses, 50 ms pulse duration, and 0.95 s between pulses [63]. D: The conditions included two
voltage steps per cycle. The first voltage was 150 V for 0.25 ms and then 5 V for 5 ms. This combination of voltages was applied 5 times
[47]. In all four images, cells were transfected and expressed tdTomato in the flatmount. In most cases, tdTomato accumulated in cells of the
cornea, ciliary body, and to a somewhat lesser extent in the RPE. In A, B, and C, there is evidence of red fluorescence in the corneal endothelium.
Some of the expression was off center from the position of the anode. In one case there was some evidence of burn damage. The scale bar
represents 1 mm.
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2221two  stronger  blood  vessels.  It  should  be  noted  that  bleb
formation  is  also  used  as  a  sign  for  successful  subretinal
injection in human patients [6,7,9,14].
The use of VidisicR helped in the rapid evaluation of the
fundus. It provided enough optical shape that the fundus was
readily apparent. Also, this obviated the need to compress or
distort the shape of the cornea with a coverslip, which would
put pressure on the delicate subretinal blebs. Eliminating the
need for a coverslip increased the percentage of successful
surgeries. Methylcellulose was used occasionally, and it is a
realistic alternative; however, the VidisicR seemed to sag less
and spread less.
Following subretinal injection quantum dots, there was
an  absence  of  fluorescence  in  the  vitreous  and  intense
fluorescence in the subretinal space (Figure 5). After 24 h, the
quantum dots were detected at the level of the RPE cells, and
the dots surrounded the nuclei of the RPE cells. This location
indicated that the quantum dots were internalized into the RPE
cells, and likely routes of internalization include phagocytosis
and  endocytosis.  These  two  routes  cannot  yet  be
distinguished;  other  routes  are  possible.  The  route  seems
unlikely to be pinocytosis as the nanoparticles are likely too
large to follow that route. No quantum dots were detected in
cells or interstitial spaces in the choroid or sclera, suggesting
that there was no interruption to the integrity of the RPE sheet.
It is worth noting that to keep the quantum dots dispersed,
1 mg/ml BSA [60] can be added to the suspension, and this
prevents clogging of the needle and tubing (a problem that we
noted).
After electroporation, tdTomato fluorescence was found
in a tight patch of RPE cells nearest to the positive electrode
(Figure 6 through Figure 10). No fluorescence was detected
at the negative electrode. The positive electrode positioned
under the bleb and highly concentrated plasmid are necessary
to  achieve  delivery  of  the  plasmid  into  RPE  cells  and
expression  of  tdTomato.  Under  suboptimal  conditions,
tdTomato fluorescence was detected in the cornea, ciliary
body, and iris. This result occurred with much longer pulse
durations (25 to 50 ms).
We found that the tdTomato expression was in polygonal
cells characteristic of RPE cells (Figure 6). While there was a
variety of patterns of red fluorescence within each cell (with
distinctive patterns of speckles, dots, and granularity, some
perinuclear and others not) all the cells had a polygonal shape.
In addition, we observed that RPE cells coexpress Rpe65
protein and tdTomato in the same cell (Figure 11), though in
slightly different locations within the RPE cell. This clearly
demonstrated the tdTomato expression to be within RPE cells,
which were the cells that we sought to target. The Rpe65
protein accumulated more on the apical top half of the RPE
cell, while the tdTomato accumulated more basally and more
in the perinuclear region. These patterns may suggest that
Rpe65 partitions to the smooth endoplasmic reticulum, which
is abundant on the apical side of the RPE cell, while tdTomato
may partition to the cytosol. It is not clear why tdTomato
Figure 10. Subretinal injection followed by electroporation at different voltages. In all panels 1 μl 2 mg/ml pVAX-tdTomato in water were
injected and three blebs were raised. Five different voltage settings (0, 25, 40, 70, and 100 V) were used. Electroporation followed with a
constant 1 ms pulse, 1 s interval, and 5 pulses on panels A, C, E, G, and I, and 10 pulses with panels B, D, F, H, and J. In A and B the samples
received 0 V, in C and D, 25 V, in E and F, 40 V, in G and H, 70 V, and in I and J, 100 V. Each panel represents a flatmount of the eye
excluding the lens. The tips of the florets correspond to the center of the cornea, and the central area from the midpoint or greatest bulge of
each petal inwards corresponds to the RPE sheet. The red fluorescence is punctate; each dot corresponds to a single RPE cell. When no voltage
was applied, there was no evidence of tdTomato expression (red). When 25 V was applied, there was no expression of tdTomato; however,
when 40 to 100 V were applied, there was an accumulation of tdTomato fluorescence. The scale bar represents 1 mm.
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2222expression would be perinuclear. If this protein were to be
overexpressed, it might be prone to binding to cytoskeletal
elements, or it may become a target of degradative pathways
that might compartmentalize it into an aggresome, which has
a perinuclear location.
Once  most  of  the  experimental  variability  due  to  the
surgical  step  was  reduced,  it  was  possible  to  focus  more
attention on the variability due to changes in electroporation
conditions. Our findings, similar to results from Chalberg and
coworkers [47,48] in rabbit eyes, suggest that shorter pulses
with higher voltages were more efficacious in adult mouse eye
than previous findings in vivo and in vitro in different species,
tissues, and systems. Our results (Figure 6, Figure 7, and
Figure 8) suggest an optimum near 50 V, 5 to 10 1 ms pulses,
and about a 1.5 to 2 mm gap between electrodes placed on the
surface of the sclera and cornea.
In other preliminary experiments (data not shown), we
varied the voltage from 0 to 200 V. A minimum of about 40
V was required before a substantial number of transfected
RPE  cells  were  observed.  Voltages  from  40  up  to  80  V
demonstrated  approximately  equal  numbers  of  transfected
expressing cells. Voltages beyond about 100 V resulted in
immediate  evidence  of  burn  damage  and  were  not  tested
further with pulse lengths at 1 ms or greater. Pulse lengths
were varied from 1 ms to 50 ms at different voltages. At 10 ms
or longer, the area of the flatmount that showed evidence of
transfection extended beyond the immediate location of the
electrodes as far as the cornea.
Under less than optimal conditions, in some cases there
was less fluorescence in the area over the anode (Figure 9 and
Figure 10). This suggested that there may have been tissue
damage in the area near the anode, killing transfected cells
before  they  accumulated  much  tdTomato  signal.  The
tdTomato signal in distant areas such as the cornea might
suggest bulk movement of the injected fluid due to rupture of
the subretinal blebs, uneven heating, or convection of fluid
within the eye that could transport the plasmid to ectopic sites
such as the cornea. After such movement, the plasmid could
Figure 11. TdTomato expression and RPE65 antibody staining in cryosections. The images show coexpression of endogenous Rpe65 protein
(green) and tdTomato (red) in RPE cells following subretinal injection and electroporation of the pVAX-tdTomato plasmid. A: Shown is the
red channel. B: Illustrated is the green channel. C: Shown is a composite of the green red and blue (DAPI stained nuclei) channels. D: The
red and green colocalized in the RPE cell layer (yellow) but not completely. E: There were some areas where the green of the Rpe65 protein
was observed more apically in the RPE cells and the red of the tdTomato protein was more basolateral and perinuclear. A white arrow drawn
across the panel represents an in silico section through which the red and green channels were quantified. F: Shown are the relative intensities
of red (tdTomato), green (Rpe65), and blue (DAPI) fluorescence in a plot. The intensities follow the white arrow drawn through several RPE
cells to scale below the image in E. This confocal image was obtained from a mouse eye harvested four days after injection. The RPE cells
have survived treatment and coexpress Rpe65 protein and tdTomato in the same cell, though in slightly different locations within the cell. The
Rpe65 protein accumulated more on the apical top half of the cell, while the tdTomato accumulated more basally and more in the perinuclear
region. The scale bar represents 50 μm.
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2223be delivered to these tissues by electroporation. An alternate
explanation is that some plasmid is always deposited in these
non-target  sites  and  that  long  (>1  ms)  pulses  allow
electroporation to occur further from the RPE target site.
Further experimentation with even shorter pulses and
potentially  higher  voltages  may  yield  better  optimization.
However,  these  standardized  experimental  conditions  are
adequate for testing other variables such as the utility of DNA
sequences  in  the  plasmid,  and  other  additives  that  might
improve transfection or maintain the stable expression of the
transfected gene.
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